An Antibody Produced by the Scientists to Reduce the Effect of Heart and Brain Attack

British Scientists in the third week of April 2011, at the University of Leicester produced an injectible antibody that reduces the damaging effect of heart and the brain attack on human body by more than 60 percent. Heart attacks and strokes happen because of the blood flow being blocked by a clot which doesn't allow other body parts in human body the access to oxygen.

However, the permanent damage is caused later after the heart attack which causes massive inflammation and more than 80 percent of the permanent damage which leads to death of the patient.

To deal with this problem the Scientists invented an antibiotic injection to mitigate the effect of heart attack and brain stroke on the oxygen starved cells in the human body. The team identified the enzyme called Mannan Binding Lectin-Associated Serine Protease-2(MASP-2) in the process responsible for doing the damage to human body after the heart attack and the brain stroke. They used the protein code-named OMS646 in their antibiotic injections to completely neutralize MASP-2.